Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 124, Issue 5, Pages 1887-1888Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI75224
Keywords
-
Categories
Ask authors/readers for more resources
The inactivation of NO by advanced glycation endproducts (AGEs), which accumulate on tissue proteins as a function of age and hyperglycemia, focused attention on the role of these ubiquitous posttranslational modifications in acquired impairments of vascular reactivity and other signaling processes. This observation occurred during a watershed period of basic and translational research in glycation that encompassed new pathologic phenomena and novel intervention strategies. How has the AGE paradigm for the tissue complications of aging and diabetes fared since the identification of the link between these glycation products and NO inactivation, and what lessons may be offered for future investigations?
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available